Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
CNY 32.73
(2.22%)
CNY 32.73
(2.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 368.67 Million | 48.43 Million | -7.48 Million | 362.34 Million | 465.53 Million | 516.69 Million |
| Net Income | 259.41 Million | 167.43 Million | 241.19 Million | 463.39 Million | 512.81 Million | 412.04 Million |
| Depreciation & Amortization | 25.69 Million | 26.53 Million | 20.08 Million | 12.64 Million | 15.55 Million | 14.77 Million |
| Deferred income taxes | -6.64 Million | -18.05 Million | 9.28 Million | -4.85 Million | -8.27 Million | -5.61 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 139.21 Million | -138.25 Million | -268.99 Million | -110.77 Million | -53.42 Million | 124.43 Million |
| Other non-cash items | -136.83 Million | -7.27 Million | 244.68 Thousand | -2.91 Million | -9.41 Million | -34.55 Million |
| Investing Cash Flow | -256.17 Million | 70.13 Million | -681.13 Million | -782.1 Million | -699.44 Million | -56.24 Million |
| Investments in PPE | -260.09 Million | -110.9 Million | -117.13 Million | -748.91 Million | -6.42 Million | -11.34 Million |
| Acquisitions | -10.35 Million | 8.98 Million | 2.03 Million | 17.74 Thousand | 6.43 Million | - |
| Investment purchases | -525 Million | -287 Million | -2.13 Billion | -3.26 Billion | -2.06 Billion | -1.14 Billion |
| Sales/Maturities of investments | 531.76 Million | 597.42 Million | 2.2 Billion | 3.23 Billion | 1.36 Billion | 1.09 Billion |
| Other Investing Activities | 7.51 Million | -138.37 Million | -633.81 Million | 54.34 | -6.42 Million | 1300.78 |
| Financing Cash Flow | -134.95 Million | 144.92 Million | -169.84 Million | -24.84 Million | 771.98 Million | 0.01 |
| Debt repayment | -2 Million | -150 Million | -106.56 Million | -107.27 Million | - | - |
| Dividends payments | -100.25 Million | -76.19 Million | -141.91 Million | -156.82 Million | - | - |
| Common Stock Repurchased | -13.07 Million | -8.88 Million | -4.34 Million | - | - | - |
| Common Stock Issuance | - | -141.11 Million | 4.34 Million | - | - | - |
| Other Financing Activities | -10.29 Million | 521.69 Million | 78.63 Million | 239.25 Million | 771.98 Million | - |
| Accounts receivables | -12.4 Million | -72.89 Million | -114.01 Million | -67.41 Million | -15.55 Million | 57.78 Million |
| Accounts payables | 184.7 Million | -22.09 Million | -150.3 Million | -81.3 Million | 33.77 Million | 92.57 Million |
| Inventory | -33.08 Million | -25.2 Million | -13.96 Million | 42.78 Million | -63.37 Million | -20.3 Million |
| Other working capital | 178.05 Million | -18.05 Million | 9.28 Million | -4.85 Million | -8.27 Million | 144.74 Million |
| Cash at beginning of period | 1.07 Billion | 798.51 Million | 1.65 Billion | 2.1 Billion | 1.56 Billion | 1.1 Billion |
| Cash at end of period | 1.07 Billion | 1.06 Billion | 798.51 Million | 1.65 Billion | 2.1 Billion | 1.56 Billion |
| Capital Expenditure | -260.09 Million | -110.9 Million | -117.13 Million | -748.91 Million | -6.42 Million | -11.34 Million |
| Effect of forex changes on cash | 7951.23 | -31.46 Thousand | -17.38 Thousand | 64.89 Thousand | 17.28 Thousand | -5220.75 |
| Net cash flow / Change in cash | 3.71 Million | 263.46 Million | -858.47 Million | -444.54 Million | 538.08 Million | 460.44 Million |
| Free Cash Flow | 108.58 Million | -62.47 Million | -124.61 Million | -386.56 Million | 459.11 Million | 505.34 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 62.26 Million | 65.9 Million | 110.62 Million | 259.41 Million | 85.58 Million | 43.14 Million |
| Depreciation & Amortization | - | 5.71 Million | 5.71 Million | 25.69 Million | 5.75 Million | -8.39 Million |
| Deferred income taxes | - | - | - | -6.64 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 90.33 Million | - | 139.21 Million | -45.48 Million | 19.06 Million |
| Other non-cash items | -51.71 Million | 11.07 Million | -117.43 Million | -136.83 Million | 210.6 Million | -63.36 Million |
| Investing Cash Flow | 100.74 Million | 106.2 Million | 80.22 Million | -256.17 Million | -83.13 Million | -40.2 Million |
| Investments in PPE | -87.63 Million | -113.68 Million | -60 Million | -260.09 Million | -47.18 Million | -52.06 Million |
| Acquisitions | 3.33 Million | -1.33 Million | - | -10.35 Million | -10.35 Million | 5.18 Million |
| Investment purchases | -135 Million | - | -310 Million | -525 Million | -430 Million | 100 Million |
| Sales/Maturities of investments | 110.71 Million | 218.22 Million | 370 Million | 531.76 Million | 380.24 Million | 32.85 Thousand |
| Other Investing Activities | 212.66 Million | 3 Million | 80.23 Million | 7.51 Million | 30.21 Million | -93.36 Million |
| Financing Cash Flow | 126.56 Million | -112.52 Million | -100.57 Million | -134.95 Million | -3.07 Million | -204.61 Million |
| Debt repayment | -129.33 Million | -98.18 Million | -98 Million | -2 Million | -2 Million | -100 Million |
| Dividends payments | -958.33 Thousand | -209.5 Million | -1.52 Million | -100.25 Million | -99.76 Million | -101.38 Million |
| Common Stock Repurchased | 39.75 Thousand | -39.75 Thousand | - | -13.07 Million | -13.07 Million | 13.05 Million |
| Common Stock Issuance | - | - | - | - | - | -13.05 Million |
| Other Financing Activities | -1.81 Million | -208.45 Million | -2.57 Million | -10.29 Million | 120.09 Million | -3.23 Million |
| Accounts receivables | - | 99.35 Million | - | -12.4 Million | -12.4 Million | 30.45 Million |
| Accounts payables | - | - | - | 184.7 Million | - | - |
| Inventory | - | -9.02 Million | - | -33.08 Million | -33.08 Million | -11.38 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.07 Billion | 1.05 Billion | 1.07 Billion | 1.07 Billion | 868.18 Million | 1.08 Billion |
| Cash at end of period | 1.31 Billion | 1.12 Billion | 1.05 Billion | 1.07 Billion | 1.07 Billion | 835.09 Million |
| Capital Expenditure | -87.63 Million | -113.68 Million | -60 Million | -260.09 Million | -47.18 Million | -52.06 Million |
| Effect of forex changes on cash | 203.07 Thousand | -89.47 Thousand | -148.81 Thousand | 7951.23 | 204.09 Thousand | -61.54 Thousand |
| Net cash flow / Change in cash | 237.35 Million | 69.14 Million | -24.14 Million | 3.71 Million | 208.54 Million | -254.43 Million |
| Free Cash Flow | -77.08 Million | -42.41 Million | -66.81 Million | 108.58 Million | 243.26 Million | -61.61 Million |
0139
ABCGAS
300908
BEEF
VIRATCRA
ALTA